LegisTrack
Back to all bills
HRES 699119th CongressIn Committee

Expressing support for the designation of September 2025 as "National Polycystic Kidney Disease Awareness Month", and raising awareness and understanding of polycystic kidney disease.

Introduced: Sep 11, 2025
Healthcare
Standard Summary
Comprehensive overview in 1-2 paragraphs

This House resolution expresses support for designating September 2025 as “National Polycystic Kidney Disease Awareness Month.” It aims to raise public awareness and understanding of polycystic kidney disease (PKD), a common genetic kidney disorder. The bill highlights the impact of PKD on individuals and families, notes the disease can affect multiple organ systems, and acknowledges the limited treatment options and absence of a cure. It also recognizes the PKD Foundation and its work in research, education, advocacy, and fundraising, and encourages nationwide activities to promote awareness and understanding. It is a ceremonial, non-binding resolution. It does not create new laws or funding, but it expresses support for awareness efforts and encourages participation in related activities and events.

Key Points

  • 1Designates September 2025 as “National Polycystic Kidney Disease Awareness Month” and supports this designation.
  • 2Seeks to raise public awareness and understanding of PKD and its impact on individuals and their families.
  • 3Highlights PKD as a progressive, genetic kidney disorder that can affect the kidneys and other organ systems, with significant health and financial consequences.
  • 4Acknowledges the limited treatment options and no current cure, and calls for additional research to find treatments and a cure.
  • 5Encourages broad participation in awareness efforts and recognizes the PKD Foundation’s role in research, education, advocacy, and fundraising (including the Walk for PKD).

Impact Areas

Primary group/area affected: People with polycystic kidney disease and their families, who stand to benefit from increased awareness, understanding, and potential future advocacy and support.Secondary group/area affected: Healthcare providers, researchers, and patient-advocacy organizations, along with the PKD Foundation and other support networks that educate and assist affected individuals.Additional impacts: May help mobilize public interest, fundraising, and policy attention toward PKD research and patient support; as a non-binding resolution, it signals support but does not authorize new programs or funding.
Generated by gpt-5-nano on Oct 8, 2025